Information:
Error:
ID
34140
Description
Rivaroxaban in Patients With Atrial Fibrillation and Coronary Artery Disease Undergoing Percutaneous Coronary Intervention; ODM derived from: https://clinicaltrials.gov/show/NCT02334254
Link
https://clinicaltrials.gov/show/NCT02334254
Keywords
Versions (1)
- 1/14/19 1/14/19 -
Copyright Holder
see on clinicaltrials.gov
Uploaded on
January 14, 2019
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Atrial Fibrillation NCT02334254
Eligibility Atrial Fibrillation NCT02334254
- StudyEvent: Eligibility
Similar models
Eligibility Atrial Fibrillation NCT02334254
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
ID.1
Item
a long-term indication for oral anticoagulation treatment (until at least 1 year after the study)
boolean
ID.2
Item
a severe coronary lesion (at least 75% stenosis on angiography or fractional flow reserve lower than 0•80) with indication for pci
boolean
ID.3
Item
age 18-80 years
boolean
ID.4
Item
history of intracranial bleeding;
boolean
ID.5
Item
cardiogenic shock;
boolean
ID.6
Item
contra indication to use of antiplatelet or anticoagulation drugs;
boolean
ID.7
Item
peptic ulcer in the previous 6 months;
boolean
ID.8
Item
thrombo cytopenia (platelet concentration lower than 50~10⁹/l);
boolean
ID.9
Item
major bleeding (according to the thrombolysis in myocardial infarction [timi] criteria) in the past 12 months; and
boolean
ID.10
Item
pregnancy.
boolean